Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04351880 · ClinicalTrials.gov registry record · NA

Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge

A NA study of Cancer and Heart Failure, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
650
Enrollment target
2
Study locations

NCT04351880 is a NA study of Cancer and Heart Failure that has completed, run by Kaiser Permanente. The registered enrollment target is 650 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04351880, a NA study of Cancer and Heart Failure, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
650 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine if medically tailored meals provided for either 2 weeks or 4 weeks (1 meal per day) to a Kaiser Permanente Colorado (KPCO) member after hospital discharge will improve their health. Medically tailored meals (MTM) are meals that are approved by a dietitian and shown to help people with certain health conditions.

Interventions

  • OTHER Medically Tailored Meals

Study Locations (2)

Colorado

  • St Joseph's Hospital - Denver
  • Good Samaritan Medical Center - Lafayette

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2020-04-16
Est. Completion 2021-12-31
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT04351880

The ClinicalTrials.gov registry entry for NCT04351880 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Medically Tailored Meals is the first listed.

NCT04351880 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04351880 about?

NCT04351880 is a clinical study titled "Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge". The purpose of this study is to determine if medically tailored meals provided for either 2 weeks or 4 weeks (1 meal per day) to a Kaiser Permanente Colorado (KPCO) member after hospital discharge will improve their health. Medically tailored meals (MTM) are meals that are approved by a dietitian an...

What is the current status of trial NCT04351880?

This trial is currently completed. It is a NA study. The enrollment target is 650 participants. The study started on 2020-04-16. Estimated completion is 2021-12-31.

What conditions does trial NCT04351880 study?

This clinical trial studies the following conditions: Cancer, Heart Failure, Diabetes Mellitus, End Stage Renal Disease, COPD.

What interventions are being tested in trial NCT04351880?

The interventions under investigation include: Medically Tailored Meals (OTHER).

Who is sponsoring clinical trial NCT04351880?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04351880 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.